CLOs on the Move

Sutro Biopharma

www.sutrobio.com

 
At Sutro Biopharma, a clinical stage company, we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next generation cancer therapeutics and autoimmune disease — Antibody Conjugates, Bispecific Antibodies and cytokine derivatives. Unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.sutrobio.com
  • 310 Utah Avenue Suite 150
    South San Francisco, CA USA 94080
  • Phone: 650.392.8412

Executives

Name Title Contact Details
Greg Chow
 Chief Financial Officer Profile
Jane Chung
 Chief Executive Officer Profile
David Pauling
 General Counsel Profile

Similar Companies

Althera

Althera Pharmaceuticals, a company focused on heart health, announces FDA approval of Roszet (rosuvastatin and ezetimibe) tablets. Founded in 2010, Althera develops innovative patient focused medicines to improve cardiovascular health.

Mission Cancer + Blood

As you or a loved one fight the unimaginable, we are right by your side, and right next door. Mission is a community-based healthcare team...

Capital i

BeClinic | Best WordPress theme for clinics and medicine

Alfa Aesar

Alfa Aesar, a Johnson Matthey Company, is a leading international manufacturer and supplier of research chemicals, metals and materials. With 30,000 products listed in the catalogue, Alfa Aesar is the single source for customers' chemical and material

Boulder iQ